Trinity will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston.

Trinity, a leading global life sciences consulting firm, today announced it will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston. Trinity’s Krista Perry will be presenting at the conference to highlight Trinity’s continued involvement supporting companies commercializing products for rare diseases, including our significant experience with gene and cell therapies. With Trinity as a key sponsor, this event brings together 450+ industry leaders and experts from innovative biotechs, large pharma, academia and key service provider companies to provide the latest and a comprehensive insight into the impact of gene therapy today and its evolution in the future. Additional Trinity members in attendance will include Christian Frois, Blair Miller, Rachel Halperin, and Mahaney Sippel. http://bit.ly/gtherap

See all News posts